Defibtech Receives License from Health Canada to Market AEDs in Canada
GUILFORD, CT – January 10, 2005 – Defibtech, a leading innovator in the Automated External Defibrillation (AED) market, today announced that it has received approval to market its devices in Canada.
The certification process included a full quality system audit, ISO 13485 standard (Quality systems - Medical devices), under CMDAS (Canadian Medical Device Conformity Assessment System). The Therapeutic Products Directorate under Health Canada issued the medical device license for all products and accessories in the Lifeline and Reviver family of devices.
The Defibtech AED features industry leading biphasic defibrillation technology, self-testing capability, simple and intuitive user interface and voice prompts, longest operational battery life (up to 7 years), and a professional-grade, real-world rugged design. The standard AED package includes everything a customer needs to completely deploy this lifesaving solution, including the AED, defibrillation pads and a 5-year, 125-shock battery pack.
About Defibtech
Defibtech relentlessly pursues one goal: making the best automatic external defibrillators (AEDs) in the world at affordable prices. Defibtech designs and manufactures the FDA-cleared Lifeline™ and ReviveR™ brand AEDs and related accessories. Defibtech's products are sold through its network of distribution partners in the United States and around the world. Founded in 1999, Defibtech is headquartered in Guilford, Connecticut and manufactures all of its defibrillators in the United States in state-of-the-art ISO 13485:2003 certified facilities. For more information about Defibtech and its products, visit www.defibtech.com or call 1-866-DEFIB-4-U (1-866-333-4248).
Contact
Defibtech, LLC
Greg Slusser
Vice President, Sales & Marketing
866-333-5641
greg@defibtech.com
or Defibtech Sales:
866-333-4248
sales@defibtech.com
|
